Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 250 of 976 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 03/05/25
End: 10/30/25
Due: 10/30/26
Phase: N/A
Priority: Normal
Start: 12/02/15
End: 11/01/18
Due: 11/01/19
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 08/13/18
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 04/30/08
Due: 04/30/09
Phase: N/A
Priority: Normal
Start: 02/12/19
End: 05/01/21
Due: 05/01/22
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 01/31/12
Due: 01/31/13
Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 10/16/19
End: 02/20/23
Due: 02/20/24
Phase: N/A
Priority: Normal
Start: 01/01/10
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 03/27/17
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 03/14/22
End: 10/01/23
Due: 10/01/24
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 11/30/12
Due: 11/30/13